Electromed, Inc. Renews Its $2,500,000 Revolving Line of Credit with Choice Financial Group
December 15, 2023 at 08:31 am EST
Share
On December 13, 2023, Electromed, Inc. (the "Company") renewed its $2,500,000 revolving line of credit with Choice Financial Group pursuant to a supplemental rider to the existing Business Loan Agreement (Asset Based) dated December 18, 2019. The rider provides that the line of credit will be extended for an additional two years and is now scheduled to mature on December 18, 2025. Interest on borrowings on the line of credit, if any, will remain at prime rate less 1.00%, with no interest rate floor and payable monthly.
The amount eligible for borrowing on the line of credit will remain limited to the lesser of $2,500,000 or 57.00% of eligible accounts receivable. Payment obligations under the line of credit remain secured by a security interest in substantially all the tangible and intangible assets of the Company.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
ELECTROMED, INC. 
